Topic: Skin Cancer
CHICAGO (Reuters) - Tests of tumor samples taken before and after treatment with an experimental melanoma pill helped researchers find the right dose in early stage testing, an approach that may boost the drug's chances of success and aid in developing others, ...
CHICAGO (Reuters) - Tests of tumor samples taken before and after treatment with an experimental melanoma pill helped researchers find the right dose in early stage testing, an approach that may boost the drug's chances of success and aid in developing others, ...
An experimental therapy that targets the protein that feeds certain types of advanced skin cancer has successfully shrunk tumors in up to 80 percent of test patients, a study has indicated. The orally-administered medication, called PLX4032, "shuts off" tumors by neutralizing a ...
LONDON (Reuters) - Treating tumors with salmonella bacteria can induce an immune response that kills cancer cells, scientists have found -- a discovery that may help them create tumor-killing immune cells to inject into patients. Researchers from Italy and the United States ...
NY eyes ways to curb teen tanning, citing cancer risk of indoor salonsNew York health officials are ramping up their regulation of more than 2,000 tanning salons and gyms offering indoor ultraviolet rays even as health advocates push for a law banning ...
'ARE WE THERE YET?' The longest summer drive on average this year will be about 8.5 hours each way, according to a recent survey. If you have children and could only bring one trip accessory — GPS, DVD player, gaming device — ...
NEW YORK (Reuters) - A senator on Sunday called on the FDA to reveal findings on a possible link between a chemical found in most sunscreens and skin cancer. The U.S. Food and Drug Administration has been reviewing data from several studies ...
Medical researchers are posting optimism in the long fight against cancer as advances were unveiled to combat the disease that continues to rise and remains the second biggest killer in the world. "Our growing understanding of cancer's complex behavior is being translated ...
Celldex Therapeutics skin cancer drug meets goal in midstage study, shares slip on resultsDrug developer Celldex Therapeutics Inc. said Monday its potential advanced skin cancer treatment met key midstage study goals. The drug candidate, CDX-011, prompted an overall response rate of 15 ...
A new experimental drug developed by Bristol-Myers Squibb and Medarex extends the lives of patients with advanced melanoma, the deadliest form of skin cancer, researchers said Saturday. The results paved the way for dealing with a form of cancer that has few ...